Andy Thorpe - Chief Financial Officer (CFO) | Albumedix

Executive Management

Don deBethizy Chairman, Board of Directors

Peter Rosholm Chief Executive Officer

Jonas S. Møller Chief Operating Officer

Phil Morton Chief Technology Officer

Andy Thorpe Chief Financial Officer

Stuart Woodward Chief Manufacturing Officer

Chris Lloyd-Jones Human Resources Director

Andy Thorpe Chief Financial Officer

B.sc., ACA

Andy Thorpe has a strong financial background and sound business understanding of the biopharmaceutical industry. Mr. Thorpe brings a long legacy with Albumedix under its former owners of Aventis, Sanofi and Novozymes for over 20 years. Prior to that Andy qualified as a chartered accountant with Arthur Andersen in their audit division.

CONTACT

Albumedix Ltd.
Castle Court
59 Castle Boulevard
Nottingham
NG7 1FD, United Kingdom
Tel: +44 115 9553379
info@albumedix.com

Albumedix - Dedicated to Better Health

Albumedix is a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilizing our albumin-based drug enhancing technologies. We partner with excellence to improve therapies for people with serious diseases. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical companies worldwide. Headquartered in Nottingham, England with more than 80 people all committed to improving patient quality of life. We are just as passionate about albumin and albumin-enabled therapies today as we were when we started 30 years ago.

Privacy | Cookies

About Management

Executive Management

CONTACT

Albumedix - Dedicated to Better Health

FOLLOW US